Intervention

H56:IC31

ClinicalTrials.gov intervention label

Clinical trials3

Recruiting0

Common conditions4

Lead sponsors shown2

Clinical trials

3 shown

Study to Evaluate H56:IC31 in Preventing Rate of TB RecurrenceNCT03512249 · 2019-01-31

A Phase I Study of Safety & Immunogenicity of AERAS-456 in HIV-Neg. Adults Treated for Drug-susceptible Pulmonary TBNCT02375698 · 2014-11-21

Safety and Immunogenicity Study of AERAS-456 Vaccine for TuberculosisNCT01967134 · 2011-11-01

Common conditions

Latent Tuberculosis1 Latent Tuberculosis Bacteriology and Histology Unknown1 Tuberculosis1 Tuberculosis, Pulmonary1

Leading sponsors

Aeras2 International AIDS Vaccine Initiative1

Trial status mix

COMPLETED3

Phase mix

PHASE12

PHASE21

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.